Skip to main content Back to Top

Advocating for Impact: 2021 State Provider Status Legislation Midyear Review

Broadcast Date: August 3, 2021


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast will review notable state legislation from the first half of 2021 with a specific focus on laws that expand pharmacists’ scope of practice and laws requiring insurers to reimburse pharmacists for clinical services. Speakers will also discuss how state efforts fit into the larger national push for pharmacist provider status.


Kyle RobbKyle Robb, PharmD, BCPS currently serves as State Policy & Advocacy Associate at the ASHP. Kyle supports ASHP members and State Affiliates as they seek to advance the practice of pharmacy through engagement with state government.

Kyle is an alumnus of the Virginia Commonwealth University/American College of Clinical Pharmacy/American Society of Health-System Pharmacists Congressional Health Care Policy Fellow Program and served as a Health Policy Fellow on the staff of the U.S. Senate Committee on Health, Education, Labor & Pensions. Prior to working in policy, Kyle was a pharmacist at the University of Virginia Health System.

Bayli LarsonBayli Larson, Pharm.D., M.S., BCPS is Strategic Initiatives Associate at ASHP in Bethesda, MD. In her role she helps manage and lead a variety of collaborative cross-organizational strategic activities to help advance ASHP’s mission and vision. Bayli recently completed the ASHP Executive Fellowship in Association Leadership and Management at ASHP and prior to that completed an ASHP-accredited PGY1 residency at UCHealth Memorial Hospital in Colorado Springs, Colo., and earned her Pharm.D. from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in 2018. She previously obtained a bachelor’s degree in Microbiology and a master’s degree in Environmental Health: Toxicology from Colorado State University.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.